Biofrontera Inc./$BFRI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Ticker
$BFRI
Sector
Primary listing
Employees
89
Headquarters
Website
Biofrontera Inc. Metrics
BasicAdvanced
$10m
-
-$1.02
0.91
-
Price and volume
Market cap
$10m
Beta
0.91
52-week high
$1.19
52-week low
$0.54
Average daily volume
191k
Financial strength
Current ratio
1.205
Quick ratio
0.995
Long term debt to equity
118.913
Total debt to equity
127.249
Interest coverage (TTM)
-22.78%
Profitability
EBITDA (TTM)
-10.565
Gross margin (TTM)
77.29%
Net profit margin (TTM)
-25.66%
Operating margin (TTM)
-24.84%
Effective tax rate (TTM)
-0.24%
Revenue per employee (TTM)
$490,000
Management effectiveness
Return on assets (TTM)
-32.41%
Return on equity (TTM)
-339.04%
Valuation
Price to revenue (TTM)
0.216
Price to book
1.65
Price to tangible book (TTM)
2.9
Price to free cash flow (TTM)
-1.001
Free cash flow yield (TTM)
-99.87%
Free cash flow per share (TTM)
-0.857
Growth
Revenue change (TTM)
13.70%
Earnings per share change (TTM)
-39.60%
3-year revenue growth (CAGR)
16.03%
3-year earnings per share growth (CAGR)
-55.57%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs